Geron Corporation (GERN) vs Inventiva S.A. Sponsored ADR (IVA)

Geron Corporation and Inventiva S.A. Sponsored ADR are both Biotechnology companies. Geron Corporation and Inventiva S.A. Sponsored ADR are of similar size ($790.2M and $740.0M). Inventiva S.A. Sponsored ADR grew revenue faster over the last twelve months: 547.9% against 24.4%. Geron Corporation has the higher net margin (−33.1% vs −750.3%) and the lower return on invested capital (−89.9% vs 0.00%). Across the 18 metrics below, Geron Corporation leads on 9 and Inventiva S.A. Sponsored ADR on 9.

Valuation

Metric GERN IVA Biotechnology median
P/E n/m n/m 8.50
P/S 3.84 5.79 9.71
P/B 3.59 1.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.01 0.64
EV/Sales 3.29 (0.10) 9.21
Earnings yield (9.01%) (121.19%) (33.15%)
Free cash flow yield (14.62%) (120.95%) (25.50%)

Profitability

Metric GERN IVA Biotechnology median
Gross margin 93.51% 0.00% 65.16%
Operating margin (25.31%) 0.00% 0.00%
Net margin (33.05%) (750.28%) 0.00%
Free cash flow margin (56.10%) 0.00% 0.00%
Return on equity (28.28%) 0.00% (56.36%)
Return on assets (12.59%) 0.00% (48.04%)
Return on invested capital (89.85%) 0.00% 0.00%

Growth

Metric GERN IVA Biotechnology median
Revenue growth (TTM) 24.39% 547.89% 6.02%
EPS growth (last fiscal year) 51.85% 35.44% 30.26%
Revenue growth, 5-year CAGR 273.49% 8.33% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GERN IVA Biotechnology median
Debt to equity 0.55 1.13 0.00
Current ratio 6.92 3.81 4.72
Net debt to EBITDA 3.28 0.29 0.96

Dividend

Metric GERN IVA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GERN IVA Biotechnology median
Market cap 790.24m 739.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack